Mkt Cap $5M
52-Week Range
Liminatus Pharma, Inc.
No significant events in the past 90 days.
$5M
Market Cap
—
Revenue
-$3M
Net Income
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.
No significant events in the past 90 days.